FDA Approves Pembrolizumab for Patients with Non-Small Cell Lung Cancer

| February 10, 2017 | 0 Comments
FDA Approves Pembrolizumab for Patients with Non-Small Cell Lung Cancer

The FDA has approved the drug pembrolizumab to treat patients with advanced non-small cell lung cancer (NSCLC) whose tumors express a protein called PD-L1.
See Original Article

Mouse Study Points to Mechanism Linking Obesity and Colorectal Cancer Risk

A missing hormone in obese mice may help explain a longstanding association between obesity and an increased risk of colorectal cancer in humans.
See Original Article

Bringing Precision to Screening for Cancer

A recent NCI-sponsored conference brought together leading screening and cancer control researchers to discuss the state of the science of precision screening for five cancers.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply